AGOMAB THERAPEUTICS NV

AGMBNASDAQ

🏆 #2164 by market capEarnings Mar 3US Equity

$674.28▼ $40.05 (−5.94%)

Simulated price

1h—

24h▼ 5.9%

7d▲ 4610.3%

14d▲ 5350.9%

30d▲ 5470.3%

1y—

🏦Market Cap

$853M

Small Cap

📈Revenue Growth (YoY)

—

📊Gross Margin

—

💵FCF Margin

—

⚖️P/S Ratio

—

Otter Score

Weak

🔭

No analyst ratings for AGMB

We don't have Wall Street analyst coverage for this ticker yet. Ratings and price targets appear here as firms publish them.